AUTOIMMUNE LIVER DISEASE

Ahmed, 1997, Liver transplantation for autoimmune hepatitis: A 12-year experience, Transplant Proc, 29, 496, 10.1016/S0041-1345(96)00223-0 Akisawa, 1997, Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis, J Hepatol, 26, 845, 10.1016/S0168-8278(97)80251-6 Anand, 1996, End-stage primary biliary cirrhosis in a first generation migrant South Asian population, Eur J Gastroenterol Hepatol, 8, 663 Angulo, 1999, Oral nicotine in treatment of primary sclerosing cholangitis: A pilot study, Dig Dis Sci, 44, 602, 10.1023/A:1026673811278 Angulo, 1998, Bone disease in patients with primary sclerosing cholangitis: Prevalence, severity and prediction of progression, J Hepatol, 29, 729, 10.1016/S0168-8278(98)80253-5 Antonio Olivera, 1993, [Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies], Rev Gastroenterol Mex, 58, 220 Archimandritis, 1995, Sjogren's syndrome with antimitochondrial antibody-negative primary biliary cirrhosis: A case of autoimmune cholangitis, J Clin Gastroenterol, 20, 268, 10.1097/00004836-199504000-00030 Altschuler, 1999, Mycophenolate mofetil for primary biliary cirrhosis and sclerosis cholangitis?, Nephrol Dial Transplant, 14, 798, 10.1093/ndt/14.3.798b Ascher, 1995, Primary sclerosing cholangitis: Liver transplantation or biliary surgery, Liver Transpl Surg, 1, 256, 10.1002/lt.500010411 Bach, 1998, The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis, Arch Pathol Lab Med, 122, 342 Balan, 1999, Autoimmune liver diseases. Recurrence after liver transplantation, Surg Clin North Am, 79, 147, 10.1016/S0039-6109(05)70011-6 Ballot, 1996, Detection on immunoblot of new proteins from the microsomal fraction recognized by anti-liver-kidney microsome antibodies type 1, Clin Immunol Immunopathol, 80, 255, 10.1006/clin.1996.0121 Ballot, 1996, Detection on immunoblot of new proteins from the soluble fraction of the cell recognized either by anti-liver-kidney microsome antibodies type 1 or by anti-liver cytosol antibodies type 1–relationship with hepatitis C virus infection, Clin Immunol Immunopathol, 80, 245, 10.1006/clin.1996.0120 Bansi, 1997, Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: A comparison of the alkaline phosphatase and immunofluorescent techniques, Eur J Gastroenterol Hepatol, 9, 575, 10.1097/00042737-199706000-00005 Bansi, 1995, Antineutrophil cytoplasmic antibodies in autoimmune hepatitis [letter], Gastroenterology, 109, 2049, 10.1016/0016-5085(95)90785-8 Barreda, 1989, [Primary sclerosing cholangitis associated with Sjo–augren's syndrome, retroperitoneal fibrosis and chronic pancreatitis. Report of a case], Revista Gastroenterologia Peru, 9, 106 Baruch, 1999, A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis, Am J Gastroenterol, 94, 3000, 10.1111/j.1572-0241.1999.01450.x Bassendine, 1985, Platelet associated immunoglobulins in primary biliary cirrhosis: A cause of thrombocytopenia?, Gut, 26, 1074, 10.1136/gut.26.10.1074 Bateson, 1998, Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival, Postgrad Med J, 74, 482, 10.1136/pgmj.74.874.482 Bayer, 1998, Transforming growth factor-beta 1 in autoimmune hepatitis: Correlation of liver tissue expression and serum levels with disease activity, J Hepatol, 28, 803, 10.1016/S0168-8278(98)80230-4 Bayraktar, 1997, A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: The role of interferon in the development of autoimmune diseases, Hepatogastroenterology, 44, 417 Bëchade, 1996, [Appearance of hepatitis C virus replication and increase of aminotransferase activity after corticoid treatment of presumed autoimmune hepatitis. 2 cases], Gastroenterol Clin Biol, 20, 696 Becker-Müller, 1991, [A rare combination of two autoimmune diseases (scleroderma, primary biliary cirrhosis) in relation to parietal cell antibodies], Leber Magen Darm, 21, 170 Bellary, 1995, Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: Favorable response to prednisone and azathioprine, Ann Intern Med, 123, 32, 10.7326/0003-4819-123-1-199507010-00004 Belle, 1995, An update on liver transplantation in the United States: Recipient characteristics and outcome, 19 Ben-Ari, 1993, Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis, Hepatology, 18, 10, 10.1002/hep.1840180103 Berdal, 1998, [Incidence and prevalence of autoimmune liver diseases], Tidsskr Nor Laegeforen, 118, 4517 Berenguer, in press Bergasa, 1998, Primary biliary cirrhosis in patients with breast cancer: Studying the link, Med Hypotheses, 50, 465, 10.1016/S0306-9877(98)90263-8 Beswick, 1985, Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history, Gastroenterology, 89, 267, 10.1016/0016-5085(85)90325-7 Biagini, 1991, Prognosis in primary biliary cirrhosis, A review Italian Journal of Gastroenterology, 23, 222 Bianchi, 1996, Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience, Dig Dis Sci, 41, 166, 10.1007/BF02208600 Bimbaum, 1997, Recurrence of autoimmune hepatitis in children after liver transplantation, J Pediatr Gastroenterol Nutr, 25, 20, 10.1097/00005176-199707000-00003 Björkland, 1994, Is primary biliary cirrhosis an autoimmune disease?, Scand J Gastroenterol Suppl, 204, 32, 10.3109/00365529409103623 Bjoro, 1999, Liver transplantation in the Nordic countries, 1982–1998: Changes of indications and improving results [see comments], Scand J Gastroenterol, 34, 714, 10.1080/003655299750025930 Boberg, 1998, Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population, Scand J Gastroenterol, 33, 99, 10.1080/00365529850166284 Boberg, 1996, Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis, Hepatology, 23, 1369, 10.1002/hep.510230612 Boberg, 1997, [Treatment of cholestatic liver diseases with ursodeoxycholic acid], Tidsskr Nor Laegeforen, 117, 3370 Bonis, 1999, Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol [see comments], Gastroenterology, 117, 395, 10.1053/gast.1999.0029900395 Bonnand, 1999, Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis, Hepatology, 29, 39, 10.1002/hep.510290140 Boyer, 1999, Asymptomatic primary biliary cirrhosis–should everyone be treated?, Am J Gastroenterol, 94, 2 Boyer, 1997, Does primary sclerosing cholangitis recur after liver transplantation?, No! Liver Transpl Surg, 3, S24 Burak, 1998, Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate, J Hepatol, 29, 990, 10.1016/S0168-8278(98)80128-1 Cameron, 1992, Primary sclerosing cholangitis: Palliative surgery or transplantation?, HPB Surg, 5, 275, 10.1155/1992/57190 Cassani, 1997, Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile, Hepatology, 26, 561, 10.1002/hep.510260305 Cello, 1989, Acquired immunodeficiency syndrome cholangiopathy: Spectrum of disease, Am J Med, 86, 539, 10.1016/0002-9343(89)90381-1 Chazouilleres, 1998, Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy, Hepatology, 28, 296, 10.1002/hep.510280203 Chen, 1997, Primary biliary cirrhosis associated with mixed type autoimmune hemolytic anemia and sicca syndrome: A case report and review of literature, Am J Gastroenterol, 92, 1547 Chen, 1998, Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis [see comments], J Gastroenterol Hepatol, 13, 483, 10.1111/j.1440-1746.1998.tb00673.x Christensen, 1989, Prognostication in primary biliary cirrhosis: Relevance to the individual patient, Hepatology, 10, 111, 10.1002/hep.1840100121 Christensen, 1993, Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups, Gastroenterology, 105, 1865, 10.1016/0016-5085(93)91086-W Christensen, 1985, Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial, Gastroenterology, 89, 1084, 10.1016/0016-5085(85)90213-6 Cho, 1999, Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: A case of autoimmune cholangitis, J Korean Med Sci, 14, 102, 10.3346/jkms.1999.14.1.102 Choudhuri, 1998, Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis, Hepatology, 28, 1177, 10.1002/hep.510280502 Cianciara, 1995, Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B, Dig Dis Sci, 40, 1842, 10.1007/BF02212711 Claise, 1996, Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases, Liver, 16, 28, 10.1111/j.1600-0676.1996.tb00700.x Combes, 1999, Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid, Hepatology, 29, 1649, 10.1002/hep.510290618 Combes, 1995, A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis, Hepatology, 22, 759 Combes, 1993, Therapy of idiopathic autoimmune chronic active hepatitis, 250 Cosserat, 1996, Immunological disorders in C virus chronic hepatitis, Nephrol Dial Transplant, 11, 31, 10.1093/ndt/11.supp4.31 Cosme, 1998, [Autoimmune hepatitis with antibodies against liver cytosol (anti-LC1)], Gastroenterol Hepatol, 21, 280 Crippin, 1998, Liver transplantation for cholestatic liver disease: Screening and assessment of risk factors, Liver Transpl Surg, 4, S2 Czaia, 1996, Autoimmune Disease Czaja, 1995, Autoantibodies, Baillieres Clin Gastroenterol, 9, 723, 10.1016/0950-3528(95)90058-6 Czaja, 1998, Frequency and nature of the variant syndromes of autoimmune liver disease, Hepatology, 28, 360, 10.1002/hep.510280210 Czaja, 1996, The variant forms of autoimmune hepatitis, Ann Intern Med, 125, 588, 10.7326/0003-4819-125-7-199610010-00009 Czaja, 1996, Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis, Hepatology, 24, 1068, 10.1002/hep.510240515 Czaja, 1995, Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis, Dig Dis Sci, 40, 33, 10.1007/BF02063938 Czaja, 1997, Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis, Hepatology, 26, 567, 10.1002/hep.510260306 Czaja, 1996, Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis, Dig Dis Sci, 41, 1733, 10.1007/BF02088738 Czaja, 1997, Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis, Hepatology, 25, 317, 10.1002/hep.510250211 Davern, 1998, Recurrent disease after liver transplantation, Semin Gastrointest Dis, 9, 86 Debray, 1999, Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis, J Pediatr, 135, 111, 10.1016/S0022-3476(99)70339-2 Degott, 1999, Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression, Hepatology, 29, 1007, 10.1002/hep.510290444 De Maria, 1996, Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period, Hepatogastroenterology, 43, 1472 Devlin, 1995, Recurrence of autoimmune hepatitis following liver transplantation, Liver Transpl Surg, 1, 162, 10.1002/lt.500010305 Dimitrewski, 1996, Recurrence of primary biliary cirrhosis in the liver allograft: The effect of immunosuppression, J Hepatol, 24, 253, 10.1016/S0168-8278(96)80001-8 Donaldson, 1994, The molecular genetics of autoimmune liver disease, Hepatology, 20, 225, 10.1002/hep.1840200133 Fernandes, 1999, Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis, Am J Gastroenterol, 94, 241, 10.1111/j.1572-0241.1999.00807.x Fimmel, 1998, A case of syncytial giant cell hepatitis with features of a paramyxoviral infection, Am J Gastroenterol, 93, 1931, 10.1111/j.1572-0241.1998.00548.x Friedrich, 1998, [Cyclosporin A in chronic active hepatitis. Results of a pilot study of 20 patients], Z Gastroenterol, 26, 265 Garcia-Buey, 1995, Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C [see comments], Gastroenterology, 108, 1770, 10.1016/0016-5085(95)90139-6 Gonzalez-Koch, 1997, The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone, J Hepatol, 27, 143, 10.1016/S0168-8278(97)80294-2 Goulis, 1999, Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis, Lancet, 354, 1053, 10.1016/S0140-6736(98)11293-X Graziadei, 1999, Recurrence of primary sclerosing cholangitis following liver transplantation, Hepatology, 29, 1050, 10.1002/hep.510290427 Gross, 1999, Quality of life before and after liver transplantation for cholestatic liver disease, Hepatology, 29, 356, 10.1002/hep.510290229 Haydon GH, Nueberger J. PBC–an infectious disease? Gut, in press Heathcote, 1999, Evidence-based therapy of primary biliary cirrhosis, Eur J Gastroenterol Hepatol, 11, 607, 10.1097/00042737-199906000-00005 Heathcote, 1999, Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis [see comments], Liver Transpl Surg, 5, 269, 10.1002/lt.500050419 Hegarty, 1984, Controlled trial of a thymic hormone extract (Thymostimulin) in “autoimmune” chronic active hepatitis, Gut, 25, 279, 10.1136/gut.25.3.279 Hendrickse, 1999, Low-dose methotrexate is ineffective in primary biliary cirrhosis: Long-term results of a placebo-controlled trial [see comments], Gastroenterology, 117, 400, 10.1053/gast.1999.0029900400 1999, International Autoimmune Hepatitis Group Report Review of criteria for diagnosis of autoimmune hepatitis, J Hepatol, 31, 929, 10.1016/S0168-8278(99)80297-9 Isaia, 1998, Bone disorders in cholestatic liver diseases, Forum (Genova), 8, 28 Jeyarajah, 1998, Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process?, Transplantation, 66, 1300, 10.1097/00007890-199811270-00006 Johnson, 1995, Azathioprine for long-term maintenance of remission in autoimmune hepatitis, N Engl J Med, 333, 958, 10.1056/NEJM199510123331502 Jones, 1999, Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis, Eur J Gastroenterol Hepatol, 11, 1165, 10.1097/00042737-199910000-00015 Joplin, 1992, Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis, Lancet, 339, 93, 10.1016/0140-6736(92)91001-O Kanzler, 1997, Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis–report of three cases, Z Gastroenterol, 35, 571 Kaplan, 1997, The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis, Semin Liver Dis, 17, 129, 10.1055/s-2007-1007191 Kaplan, 1999, prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis, Gastroenterology, 117, 1173, 10.1016/S0016-5085(99)70403-8 Kaserbacher, 1996, Therapy of primary biliary cirrhosis with p-tolylmethylcarbinol nicotinic acid ester in combination with alpha-naphthylacetic acid, Wien Klin Wochenschr, 108, 722 Kita, 1998, Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: Report of a case, Transplant Proc, 30, 3321, 10.1016/S0041-1345(98)01047-1 Koskinas, 1999, Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis, Eur J Gastroenterol Hepatol, 11, 1421, 10.1097/00042737-199912000-00014 Krom, 1989, The first 100 liver transplantations at the Mayo Clinic, Mayo Clin Proc, 64, 84, 10.1016/S0025-6196(12)65307-5 Kubota, 1999, Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation, Journal of Hepatobiliary and Pancreatic Surgery, 6, 377, 10.1007/s005340050134 Langnas, 1990, Primary sclerosing cholangitis: The emerging role for liver transplantation, Am J Gastroenterol, 85, 1136 Launay, 1997, [Autoimmune hepatitis treated with cyclosporin revealed by acute hepatocellular failure], Arch Pediatr, 4, 40, 10.1016/S0929-693X(97)84306-0 Leipold, 1997, Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis, Arthritis Rheum, 40, 1896, 10.1002/art.1780401026 Leuschner, 2000, Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment [see comments], Gut, 46, 121, 10.1136/gut.46.1.121 Leuschner, 1999, Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: Results of a prospective double-blind trial, Gastroenterology, 117, 918, 10.1016/S0016-5085(99)70351-3 Li, 2000, Autoimmune cholangitis with features of autoimmune hepatitis: Successful treatment with immunosuppressive agents and ursodeoxycholic acid [in process citation], J Gastroenterol Hepatol, 15, 95, 10.1046/j.1440-1746.2000.02054.x Lucey, 1997, Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases [see comments], Liver Transpl Surg, 3, 628, 10.1002/lt.500030613 Mac Farlane, 1993, Clinical spectrum and heterogenicity of autoimmune hepatitis: An overview, 179 Manns, 1997, Viral induction of autoimmunity: Mechanisms and examples in hepatology, J Viral Hepat, 4, 42, 10.1111/j.1365-2893.1997.tb00179.x Martinez, 1997, Relapse of sclerosing cholangitis after liver transplant in patients with hyper-IgM syndrome, Transplant Proc, 29, 432, 10.1016/S0041-1345(96)00172-8 Mason A, Farr G, Xu L, et al. Pilot study of lamivudine for patients with primary biliary cirrhosis [abstract]. J Hepatol, in press Mason, 2000, Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders, Lancet, 351, 1620, 10.1016/S0140-6736(97)10290-2 Mason, 1998, Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders, Lancet, 351, 1620, 10.1016/S0140-6736(97)10290-2 McMichael, 1996, computer guided randomized concentration-controlled trials of tacrolimus in autoimmunity: Multiple sclerosis and primary biliary cirrhosis, Ther Drug Monit, 18, 435, 10.1097/00007691-199608000-00021 McNair, 1998, Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases, Am J Gastroenterol, 93, 777, 10.1111/j.1572-0241.1998.224_a.x Mieli-Vergani, 1998, Immunological liver diseases in children, Semin Liver Dis, 18, 271, 10.1055/s-2007-1007163 Mistilis, 1985, Cyclosporin, a new treatment for autoimmune chronic active hepatitis, Med J Aust, 143, 463, 10.5694/j.1326-5377.1985.tb123140.x Mitsuyoshi, 1999, Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants, Biochem Biophys Res Commun, 263, 537, 10.1006/bbrc.1999.1403 Miyaguchi, 1998, Novel therapeutic approach to primary biliary cirrhosis patient: Anti-eosinophil strategy, Hepatogastroenterology, 45, 1457 Muratori, 1994, Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C, J Hepatol, 21, 199, 10.1016/S0168-8278(05)80395-2 Nakajima, 1996, Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C, Intern Med, 35, 376, 10.2169/internalmedicine.35.376 Neuberger, 1997, Primary biliary cirrhosis, Lancet, 350, 875, 10.1016/S0140-6736(97)05419-6 Neuberger, 1995, Recurrence of primary biliary cirrchosis, primary sclerosing cholangitis, and autoimmune hepatitis, Liver Transpl Surg, 1, 109 Omagari, 1996, Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis, Pathology, 28, 255, 10.1080/00313029600169104 Pasha, 1999, Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis, Hepatology, 29, 21, 10.1002/hep.510290116 Pawlotsky, 1994, Immunological disorders in C virus chronic active hepatitis: A prospective case-control study, Hepatology, 19, 841, 10.1002/hep.1840190407 Perrillo, 1996, Hepatitis and cholestasis in a middle-aged woman [clinical conference], Hepatology, 24, 730, 10.1002/hep.510240342 Petruff, 1998, URSO not so good for PSC, Inflammatory Bowel Disease, 4, 172, 10.1002/ibd.3780040215 Phillips, 1991, Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features, N Engl J Med, 324, 455, 10.1056/NEJM199102143240705 Polson, 1989, Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies, Gastroenterology, 97, 715, 10.1016/0016-5085(89)90643-4 Poupon, 1999, Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group, Hepatology, 29, 1668, 10.1002/hep.510290603 Poupon, 1992, Ursodeoxycholic acid for the treatment of cholestatic diseases, Prog Liver Dis, 10, 219 Poupon, 1994, Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group [see comments], N Engl J Med, 330, 1342, 10.1056/NEJM199405123301903 Rand, 1992, Successful orthotopic liver transplantation in two patients with liver failure due to sclerosing cholangitis with Langerhans cell histiocytosis, J Pediatr Gastroenterol Nutr, 15, 202, 10.1097/00005176-199208000-00019 Rebollo, 1999, Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis, Rev Esp Enferm Dig, 91, 630 Renner, 1995, [Does the primary disease recur following liver transplantation?], Ther Umsch, 52, 572 Robertson, 1987, Persistent measles virus genome in autoimmune chronic active hepatitis, Lancet, 2, 9, 10.1016/S0140-6736(87)93051-0 Ryder, 1995, Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus, Hepatology, 22, 718 Sadamoto, 1998, Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis [letter], Lancet, 352, 1595, 10.1016/S0140-6736(05)61042-2 Saeki, 1993, Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: A case report, Hepatogastroenterology, 40, 499 Sanchez-Pobre, 1996, Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis, Atypical primary biliary cirrhosis or autoimmune cholangitis? J Clin Gastroenterol, 23, 191 Sato, 1999, Primary hepatic lymphoma associated with primary biliary cirrhosis, Am J Gastroenterol, 94, 1669, 10.1111/j.1572-0241.1999.01160.x Schvarcz, 1993, Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis, J Hepatol, 18, 15, 10.1016/S0168-8278(05)80005-4 Sekido, 1999, Liver transplantation for primary sclerosing cholangitis, Journal of Hepatobiliary Pancreatic Surgery, 6, 373, 10.1007/s005340050133 Senturk, 1995, Treatment of corticosteroid-azathioprine resistant autoimmune hepatitis with cyclosporin A, Indian J Gastroenterol, 14, 110 Shiomi, 1999, Calcitriol for bone loss in patients with primary biliary cirrhosis, J Gastroenterol, 34, 241, 10.1007/s005350050250 Springer, 1999, Asymptomatic primary biliary cirrhosis: A study of its natural history and prognosis, Am J Gastroenterol, 94, 47, 10.1111/j.1572-0241.1999.00770.x Trigger, 1972, Raised antibody titres to measles and rubella viruses in chronic active hepatitis, Lancet, 1, 665, 10.1016/S0140-6736(72)90465-5 van Berge Henegouwen, 1991, [Bile acid therapy; new hope for patients with chronic liver diseases], Ned Tijdschr Geneeskd, 135, 696 Van Dam, 1997, Primary biliary cirrhosis: Dutch application of the Mayo model before and after orthotopic liver transplantation, Hepatogastroenterology, 44, 732 van de Meeberg, 1993, Therapy with ursodeoxycholic acid in cholestatic liver disease, Scand J Gastroenterol, 15, 10.3109/00365529309101569 van de Meeberg, 1996, Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: Biliary enrichment and biochemical response, J Hepatol, 25, 887, 10.1016/S0168-8278(96)80293-5 Van De Water, 1989, Detection of autoantibodies to the recombinant 74 kd and 52 kd mitochondrial autoantigens of primary biliary cirrhosis, N Engl J Med, 320, 1377, 10.1056/NEJM198905253202104 Van De Water, 1996, Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis, Hepatology, 24, 1079, 10.1002/hep.510240517 Van De Water, 1993, Molecular mimicry in primary biliary cirrhosis: Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex E2, J Clin Invest, 91, 2653, 10.1172/JCI116504 Van Thiel, 1995, Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: Results of an open-label preliminary trial, Am J Gastroenterol, 90, 455 Vento, 1991, Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals, Lancet, 337, 1183, 10.1016/0140-6736(91)92858-Y Vento, 1995, Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals, Lancet, 346, 608, 10.1016/S0140-6736(95)91438-2 Wachs, 1998, Adult living donor liver transplantation using a right hepatic lobe, Transplantation, 66, 1313, 10.1097/00007890-199811270-00008 Wiesner, 1998, Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: Predicting outcomes with natural history models, Mayo Clin Proc, 73, 575, 10.4065/73.6.575 Wiesner, 1996, Liver transplantation for primary sclerosing cholangitis: Impact of risk factors on outcome, Liver Transpl Surg, 2, 99 Wolfhagen, 1998, Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: A 1-year randomized, placebo-controlled study, J Hepatol, 29, 736, 10.1016/S0168-8278(98)80254-7 Xu, 2000, Isolation and characterization of a novel virus associated with primary biliary cirrhosis [abstract], Hepatology, 32, 297A Xu, 1997, Viral induction of primary biliary cirrhosis, J Hepatology, 26, 61